A phase I trial of a bi-weekly combination of capecitabine/irinotecan (XELIRI) then capecitabine/irinotecan/oxaliplatin (XELIRINOX) in solid tumors
Assenat, E., Kramar, A., Poujol, S., Gestin-Boyer, C., Senesse, P., Samalin, E., Portales, F., Thezenas, S., Bleuse, J., Ychou, M.
Published in Journal of clinical oncology (20.05.2009)
Published in Journal of clinical oncology (20.05.2009)
Get full text
Journal Article
Efficacy of bevacizumab in combination with irinotecan or oxaliplatin as second-line, third-line or later treatment in metastatic colorectal cancer (MCRC) patients
Lièvre, A., Samalin, E., Senesse, P., Boyer-Gestin, C., Mitry, E., Lepère, C., Bachet, J., Vaillant, J., Ychou, M., Rougier, P.
Published in Journal of clinical oncology (20.06.2007)
Published in Journal of clinical oncology (20.06.2007)
Get full text
Journal Article
Ultradian variations of interleukin-1 beta concentration (IL-1 beta), interferon gamma (IFN-gamma) and soluble IL-2 receptors (RIL-2) in healthy volunteers humen
Bouayad-Amine, D, Cupissol, D, Nougier-Soule, J, Bres, J, Gestin-Boyer, C, René, C, Assens, C, Serrou, B
Published in Comptes rendus des seances de la Societe de biologie et de ses filiales (1993)
Get more information
Published in Comptes rendus des seances de la Societe de biologie et de ses filiales (1993)
Journal Article
Prevention of cisplatin nephrotoxicity in cancer: adjusting the dosage with a computerized chrono-pump
Gestin-Boyer, C, René, C, Cupissol, D, Tep, A, Bressolle, F, Bres, J, Brun, S, Serrou, B, Pujol, H
Published in Comptes rendus des seances de la Societe de biologie et de ses filiales (1989)
Get more information
Published in Comptes rendus des seances de la Societe de biologie et de ses filiales (1989)
Journal Article